The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

HHS bypassed normal procedures as it laid off thousands of employees, according to sources. One union has already filed an ...

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

This blog delves into the rise of rare disease drug approvals and the critical importance of regulatory guidance in shaping ...

Wall Street analysts said the results for Verve’s therapy appeared competitive on efficacy, while avoiding any major safety ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...